FDA Inspection 1162020 — Ann E. Hyslop Segeren, M.D.
The FDA completed an inspection of Ann E. Hyslop Segeren, M.D. on February 4, 2022 in Palo Alto, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 4, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Palo Alto, CA (United States)
Additional Details
Clinical Investigator (CI)